Contents
Treating Polycythemia Vera: From Blood Draws to Medications
Published: Oct 18, 2023
Treating polycythemia vera (PV) is all about keeping your blood cell counts in check. Let's explore the main treatment options and how they work to keep you healthy.
Phlebotomy: The First Line of Defense
Phlebotomy is often the first treatment for PV. It's a simple procedure where some of your blood is removed, like donating blood. This helps reduce your red blood cell count quickly. Think of it as draining a bathtub that's too full - you're removing the excess to get back to a safe level.
Medications to Slow Blood Cell Production
If phlebotomy alone isn't enough, your doctor might prescribe medications to slow down your bone marrow's production of blood cells. Hydroxyurea is a common choice. It works like a brake pedal for your bone marrow, telling it to slow down the production of red blood cells. Another option is interferon, which helps your immune system regulate blood cell production.
Aspirin: Preventing Blood Clots
Low-dose aspirin is often prescribed to reduce the risk of blood clots in PV. It works by making your blood less 'sticky,' reducing the chance of clots forming. Think of it as adding a bit of oil to a squeaky hinge - it helps things flow more smoothly.
Newer Treatments: JAK Inhibitors
For some patients, a newer type of medication called JAK inhibitors might be used. These drugs, like ruxolitinib, target the genetic mutation that causes PV. They can help control symptoms and reduce spleen size in some patients. It's like using a key to lock the door on the overactive bone marrow cells.
Frequently Asked Questions
Frequency varies, but it could be every few weeks or months.
Yes, but they're usually manageable with your doctor's help.
No, PV requires ongoing management even when you feel well.
Most PV patients need long-term treatment to manage the condition.
A healthy diet is important, but won't replace medical treatment.
Your Treatment Journey
Treatment for PV is highly individualized and may change over time as your needs change.
References
- Marchioli R, Finazzi G, Specchia G, et al. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013;368(1):22-33.
- Vannucchi AM, Kiladjian JJ, Griesshammer M, et al. Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med. 2015;372(5):426-435.
- Barbui T, Tefferi A, Vannucchi AM, et al. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia. 2018;32(5):1057-1069.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?